Infinity Pharmaceuticals Inc (INFI)
2.00
+0.19 +10.50%
NASDAQ
Nov 27, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.592M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.71 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -41.28M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 39.72% |
| Profit Margin (Quarterly) | -1.92K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 128.41M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 72.97 |
| PE Ratio | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -3.540 |
| Free Cash Flow (Quarterly) | -7.883M |
| Return on Equity | Upgrade |
View All INFI News
News
-
WireHeadlineTime (ET)
-
SA Breaking News11/17 12:44
-
Yahoo11/17 09:22
-
MT Newswires11/13 12:13
-
Yahoo11/12 05:53
-
Yahoo11/09 18:35
-
MT Newswires11/09 17:17
-
Yahoo11/09 17:14
-
SA Breaking News11/09 16:23
-
MT Newswires11/09 16:13
-
Yahoo11/09 16:05
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/03/2021 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release |
| 03/03/2021 | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/09/2020 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings Result for 2020 |
| 11/09/2020 16:30 EST | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020 |
| 07/30/2020 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings Result for 2020 |
| 07/30/2020 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020 |
| 06/17/2020 | Misc | Infinity Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/11/2020 16:30 EDT | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/11/2020 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 03/03/2020 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Mar. 03, 2021
- Last Earnings Release: Nov. 09, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.00 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement
